RGBPP

Regen Biopharma (PK) (RGBPP)

Regen Biopharma Inc (PK)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:RGBPP

1 2 3 4 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
29/05/2024	19h12	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
29/05/2024	19h11	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
23/05/2024	15h32	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
23/05/2024	15h31	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
10/05/2024	21h50	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
10/05/2024	21h49	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
09/02/2024	22h15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
09/02/2024	22h14	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
19/01/2024	19h29	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
19/01/2024	19h29	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
20/11/2023	15h38	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
20/11/2023	15h37	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:RGBPP	Regen Biopharma Inc (PK)
02/10/2023	19h42	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
02/10/2023	06h15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	USOTC:RGBPP	Regen Biopharma Inc (PK)
25/09/2023	17h25	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:RGBPP	Regen Biopharma Inc (PK)
18/09/2023	22h02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
25/07/2023	21h39	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
24/07/2023	20h59	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	USOTC:RGBPP	Regen Biopharma Inc (PK)
15/05/2023	16h27	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:RGBPP	Regen Biopharma Inc (PK)
15/05/2023	12h28	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:RGBPP	Regen Biopharma Inc (PK)
13/04/2023	12h29	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:RGBPP	Regen Biopharma Inc (PK)
21/03/2023	18h52	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
07/02/2023	13h14	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
19/01/2023	21h42	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGBPP	Regen Biopharma Inc (PK)
21/11/2022	23h12	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
18/11/2022	12h37	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
15/11/2022	21h38	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
14/11/2022	18h06	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
20/09/2022	13h04	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
22/07/2022	20h43	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGBPP	Regen Biopharma Inc (PK)